難治性肺疾患研究部このページを印刷する - 難治性肺疾患研究部

2023年11月8日掲載

                                       滝本宜之

最近の活動状況

2023年7月1日から、前任の井上義一から引き継ぎ、部長就任。
これまで、呼吸不全研究部と共に共同研究を、リンパ脈管筋腫症、肺胞蛋白症に加えて、特発性PPFE、肺骨化症、アミロイドーシス等について研究を行ってきた。

過去の獲得研究費

リンパ脈管筋腫症の腫瘍進展におけるテトラスパニン・小胞輸送の病態解明
(2016-2018年 科研費 基盤C)
指定難病・リンパ脈管筋腫症における新規治療法の開発
(2017年度 公益財団法人 大阪コミュニティー財団 光・秀・裕基金(難病)助成
難病研究)
細胞外小胞に着目した包括的アプローチによるリンパ脈管筋腫症のバイオマーカー開発
(2019-2021年 科研費 基盤C)
最新プロテオミクスによる肺アミロイドーシスのバイオマーカー探索
(2022-2024年 科研費 基盤C)

過去の産業財産権

特許出願番号: 特願2018-048266、発明の名称: リンパ脈管筋腫症バイオマーカー

主な業績

  1. Takimoto T, Yanagisawa A, Arai T, Inoue Y. Vocal cord paralysis associated with pleuroparenchymal fibroelastosis: A case report and literature review. Respir Investig. 2023 Sep;61(5):548-552.
  2. Takimoto T, Sumikawa H, Arai T, Inoue Y, et al. Left vocal cord paralysis in idiopathic pleuroparenchymal fibroelastosis: A case report. JMA J. 2023 Apr 14;6(2);220-222.
  3. Takimoto T, Kobayashi T, Minomo S. Concomitant Recurrent Pneumothorax and Takotsubo Cardiomyopathy in a Chronic Obstructive Pulmonary Disease Patient. Cureus. 2022 Oct 29;14(10):e30850.
  4. Takimoto T. Corticosteroids for pulmonary lymphangitic carcinomatosis. BMJ Support Palliat Care. 2022 Oct 27:bmjspcare-2022-003983.
  5. Takimoto T, Nakamura Y. Serum Biomarkers in a Radiological Pattern of Non-Fibrotic Hypersensitivity Pneumonitis: Implications for Mechanistic Difference and Differential Diagnosis. Diseases. 2022 Jun 27;10(3):36.
  6. Takimoto T. Post-capillary pulmonary hypertension in patients with interstitial lung disease: An important but overlooked phenomenon. Respiratory investigation. 2022 Jan;60(1);180-181.
  7. Azuma K, Takimoto T, Kasai T, Hirose M, Hatsuda K, Sugimoto C, Arai T, Akira M, Inoue Y. Diagnostic yield and safety of bronchofiberscopy for pulmonary alveolar proteinosis. Respiratory investigation. 2021 May 6;S2212-5345(21)00073-3.
  8. Enomoto T, Takimoto T, Kagawa T, Tachibana K, Sugimoto C, Arai T, Sakurai T, Kasai T, Akira M, Hayashi S, Inoue Y. Histologically Proven Dendriform Pulmonary Ossification: A Five-case Series. Internal medicine (Tokyo, Japan). 2021 Feb 01.
  9. Takimoto T, Kitaoka H, Kijima T. What Is Tracheobronchomalacia in Obstructive Lung Disease? Chest. 2021 Jan;159(1):442-443. doi: 10.1016/j.chest.2020.07.085.
  10. Nakamura Y, Takimoto T, Kobayashi T, Tachibana K, Kasai T, Akira M, Arai T, Inoue Y. Drug-related pneumonitis with radiographic hypersensitivity pneumonitis pattern: Three case series. Respir Med Case Rep. 2021;34;101498.
  11. Adachi Y, Takimoto T, Takeda M, Matsumoto K, Takeuchi N, Kagawa T, Sakamoto T, Kasai T, Sugimoto C, Inoue Y, Tachibana K, Arai T, Inoue Y. Lymphoplasmacytic lymphoma involving the mediastinum and the lung, followed by amyloidosis: A surgically and genetically proven case. Respir Med Case Rep. 2020 Dec 1;31:101313.
  12. Takimoto T. Micronodular Pattern of Organizing Pneumonia or Hypersensitivity Pneumonia Induced by an Immune Checkpoint Inhibitor? American journal of respiratory and critical care medicine. 2020 11 15;202(10);1485-1486.
  13. Takimoto T, Kagawa T, Tachibana K, Arai T, Inoue Y. Massive atelectasis by mucoid impaction in an asthma patient during treatment with anti-interleukin-5 receptor antibody. Respirol Case Rep. 2020 Jun 18;8(6):e00599. 
  14. Takimoto T, Minomo S, Azuma K, Tsuyuguchi K, Suzuki K. A rare cause of pneumatosis intestinalis: Intestinal amyloidosis reactive to pulmonary Mycobacterium avium infection. Int J Infect Dis. 2020 Aug;97:329-330
  15. Takimoto T, Osa A, Morita S, Abe K. Diffuse Pulmonary Cysts in Metastatic Angiosarcoma. Intern Med. 2020 Feb 1;59(3):457-458.
  16. Futami S, Takimoto T *, Nakagami F, Satoh S, Hamaguchi M, Kuroyama M, Miyake K, Koyama S, Iwahori K, Hirata H, Nagatomo I, Takeda Y, Kida H, Kumanogoh A. A lung abscess caused by secondary syphilis - the utility of polymerase chain reaction techniques in transbronchial biopsy: a case report. BMC Infect Dis. Jul 9;19(1):598, 2019.  * Corresponding Author
  17. Hwang S, Takimoto T *, Hemler ME. Integrin-independent support of cancer drug resistance by tetraspanin CD151. Cell Mol Life Sci. Apr;76(8):1595-1604, 2019 * equally contribution
  18. Takimoto T, Kijima T, Otani Y, Nonen S, Namba Y, Mori M, Yokota S, Minami S, Komuta K, Uchida J, Imamura F, Furukawa M, Tsuruta N, Fujio Y, Azuma J, Tachibana I, Kumanogoh A. Polymorphisms of CYP2D6 Gene and Gefitinib-Induced Hepatotoxicity. Clin Lung Cancer 14(5):502-7, 2013
  19. Takimoto T, Yoshida M, Hirata H, Kashiwa Y, Takeda Y, Goya S, Kijima T, Kumagai T, Tachibana I, Kawase I. 4-Hydroxy-2-nonenal induces chronic obstructive pulmonary disease-like histopathologic changes in mice. Biochem Biophys Res Commun 420(1):84-90, 2012
  20. Takimoto T, Morita S, Osa A, Abe K. Tension Pneumomediastinum in a Patient with Interstitial Pneumonia. Intern Med 51(1):125 2012
  21. Takimoto T, Nakabori T, Osa A, Morita S, Terada H, Oseto S, Iwazawa T, Abe K. Tubular nephrotoxicity induced by docetaxel in NSCLC patients. Int J Clin Oncol 17(4):395-8, 2012
  22. Takimoto T, Morimura O, Inoue T, Terada H, Abe K. Granulomatosis with polyangitis (Wegener's). Thorax 67(6):563-4, 2012.
  23. Minomo S, Takimoto T *, Morimura O, Watanabe A, Nagate Y, Kotake T, Inoue T, Terada H, Nakata S, Abe K. Primary Pulmonary T-Cell Lymphoma in a Human T-Lymphotropic Virus Type-1 Carrier Showing Atypical Shadow. J Thorac Oncol 5(4):558-9, 2010 * Corresponding Author
  24. Takimoto T, Hara H, Mediastinal Pancreatic Pseudocysts that were Resolved following Parathyroidectomy for Primary Hyperparathyroidism. Intern Med 48(18): 1671-6, 2009
  25. Takimoto T, Yoshida M, Hirata H, Suzuki M, Yanagita M, Kashiwa Y, Inoue K, Yano Y, Hoshino S, Takeda Y, Goya S, Kijima T, Kumagai T, Osaki T, Tachibana I, Kawase I. 4-Hydroxy-2-Nonenal Induces Endothelial Cell Injury via PKCdelta and biphasic JNK Activation. EXCLI J 7:71-78, 2008
  26. Takimoto T, Hirashima T, Kobayashi M, Nitta T, Sasada S, Nakamura Y, Matsui K, Kawahara K, Kawase I. Gefitinib for previously untreated patients with non-small cell lung cancer (NSCLC)--a retrospective study of 12 patients treated in one institution. Jpn J Cancer Chemother. 32:1985-1988, 2005